|
1
|
Katsura C, Ogunmwonyi I, Kankam HK and
Saha S: Breast cancer: Presentation, investigation and management.
Br J Hosp Med (Lond). 83:1–7. 2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Turashvili G and Brogi E: Tumor
heterogeneity in breast cancer. Front Med (Lausanne).
4(227)2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Sadatmoosavi A, Tajedini O, Esmaeili O,
Abolhasani Zadeh F and Khazaneha M: Emerging trends and thematic
evolution of breast cancer: Knowledge mapping and co-word analysis.
JMIR Cancer. 7(e26691)2021.PubMed/NCBI View
Article : Google Scholar
|
|
4
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Duffy SW, Tabár L, Yen AM, Dean PB, Smith
RA, Jonsson H, Törnberg S, Chen SL, Chiu SY, Fann JC, et al:
Mammography screening reduces rates of advanced and fatal breast
cancers: Results in 549,091 women. Cancer. 126:2971–2979.
2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Gerami R, Sadeghi Joni S, Akhondi N,
Etemadi A, Fosouli M, Eghbal AF and Souri Z: A literature review on
the imaging methods for breast cancer. Int J Physiol Pathophysiol
Pharmacol. 14:171–176. 2022.PubMed/NCBI
|
|
7
|
Cserni G, Francz M, Járay B, Kálmán E,
Kovács I, Krenács T, Tóth E, Udvarhelyi N, Vass L, Vörös A, et al:
Pathological diagnosis, work-up and reporting of breast cancer 1st
Central-Eastern European professional consensus statement on breast
cancer. Pathol Oncol Res. 28(1610373)2022.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Orrantia-Borunda E, Anchondo-Nuñez P,
Acuña-Aguilar LE, Gómez-Valles FO and Ramírez-Valdespino CA:
Subtypes of Breast Cancer. In: Breast Cancer. Mayrovitz HN (ed).
Exon Publications, Brisbane, AU, 2022.
|
|
9
|
Shao J, Rodrigues M, Corter AL and Baxter
NN: Multidisciplinary care of breast cancer patients: A scoping
review of multidisciplinary styles, processes, and outcomes. Curr
Oncol. 26:e385–e397. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Riis M: Modern surgical treatment of
breast cancer. Ann Med Surg (Lond). 56:95–107. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Falzone L, Bordonaro R and Libra M:
SnapShot: Cancer chemotherapy. Cell. 186:1816–1816.e1. 2023.
|
|
12
|
Lau KH, Tan AM and Shi Y: New and emerging
targeted therapies for advanced breast cancer. Int J Mol Sci.
23(2288)2022.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Liu K, Mao X, Li T, Xu Z and An R:
Immunotherapy and immunobiomarker in breast cancer: Current
practice and future perspectives. Am J Cancer Res. 12:3532–3547.
2022.PubMed/NCBI
|
|
14
|
Zhang X, Yang H and Zhang R: Challenges
and future of precision medicine strategies for breast cancer based
on a database on drug reactions. Biosci Rep.
39(BSR20190230)2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Vella F, Filetti V, Cirrincione L,
Rapisarda V, Matera S, Skerjanc A, Cannizzaro E and Vitale E: Work
ability after breast cancer: Study of healthcare personnel
operating in a hospital of South Italy. Int J Environ Res Public
Health. 19(10835)2022.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Łukasiewicz S, Czeczelewski M, Forma A,
Baj J, Sitarz R and Stanisławek A: Breast cancer-epidemiology, risk
factors, classification, prognostic markers, and current treatment
strategies-an updated review. Cancers (Basel).
13(4287)2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Alkabban FM and Ferguson T: Breast cancer.
In: StatPearls [Internet]. StatPearls Publishing, Treasure Island,
FL, 2023. https://www.ncbi.nlm.nih.gov/books/NBK482286/.
Updated September 26, 2022.
|
|
18
|
Gucalp A, Traina TA, Eisner JR, Parker JS,
Selitsky SR, Park BH, Elias AD, Baskin-Bey ES and Cardoso F: Male
breast cancer: A disease distinct from female breast cancer. Breast
Cancer Res Treat. 173:37–48. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Lavoro A, Scalisi A, Candido S, Zanghì GN,
Rizzo R, Gattuso G, Caruso G, Libra M and Falzone L: Identification
of the most common BRCA alterations through analysis of germline
mutation databases: Is droplet digital PCR an additional strategy
for the assessment of such alterations in breast and ovarian cancer
families? Int J Oncol. 60(58)2022.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Vysotskaia V, Kaseniit KE, Bucheit L,
Ready K, Price K and Johansen*Taber K: Clinical utility of
hereditary cancer panel testing: Impact of PALB2, ATM, CHEK2, NBN,
BRIP1, RAD51C, and RAD51D results on patient management and
adherence to provider recommendations. Cancer. 126:549–558.
2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Liu L, Hao X, Song Z, Zhi X, Zhang S and
Zhang J: Correlation between family history and characteristics of
breast cancer. Sci Rep. 11(6360)2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Cohen SY, Stoll CR, Anandarajah A, Doering
M and Colditz GA: Modifiable risk factors in women at high risk of
breast cancer: A systematic review. Breast Cancer Res.
25(45)2023.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Pizot C, Boniol M, Mullie P, Koechlin A,
Boniol M, Boyle P and Autier P: Physical activity, hormone
replacement therapy and breast cancer risk: A meta-analysis of
prospective studies. Eur J Cancer. 52:138–154. 2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Vitale S, Palumbo E, Polesel J, Hebert JR,
Shivappa N, Montagnese C, Porciello G, Calabrese I, Luongo A, Prete
M, et al: One-year nutrition counselling in the context of a
Mediterranean diet reduced the dietary inflammatory index in women
with breast cancer: A role for the dietary glycemic index. Food
Funct. 14:1560–1572. 2023.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Montagnese C, Porciello G, Vitale S,
Palumbo E, Crispo A, Grimaldi M, Calabrese I, Pica R, Prete M,
Falzone L, et al: Quality of life in women diagnosed with breast
cancer after a 12-month treatment of lifestyle modifications.
Nutrients. 13(136)2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Porciello G, Montagnese C, Crispo A,
Grimaldi M, Libra M, Vitale S, Palumbo E, Pica R, Calabrese I,
Cubisino S, et al: Mediterranean diet and quality of life in women
treated for breast cancer: A baseline analysis of DEDiCa
multicentre trial. PLoS One. 15(e0239803)2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Freudenheim JL: Alcohol's effects on
breast cancer in women. Alcohol Res. 40(11)2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Yoo TK, Han KD, Kim D, Ahn J, Park WC and
Chae BJ: Hormone replacement therapy, breast cancer risk factors,
and breast cancer risk: A nationwide population-based cohort.
Cancer Epidemiol Biomarkers Prev. 29:1341–1347. 2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Seiler A, Chen MA, Brown RL and Fagundes
CP: Obesity, dietary factors, nutrition, and breast cancer risk.
Curr Breast Cancer Rep. 10:14–27. 2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Laudisio D, Castellucci B, Barrea L,
Pugliese G, Savastano S, Colao A and Muscogiuri G: Mediterranean
diet and breast cancer risk: A narrative review. Minerva Endocrinol
(Torino). 46:441–452. 2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Ubago-Guisado E, Rodríguez-Barranco M,
Ching-López A, Petrova D, Molina-Montes E, Amiano P,
Barricarte-Gurrea A, Chirlaque MD, Agudo A and Sánchez MJ: Evidence
update on the relationship between diet and the most common cancers
from the European prospective investigation into cancer and
nutrition (EPIC) study: A systematic review. Nutrients.
13(3582)2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Kroenke CH, Kwan ML, Sweeney C, Castillo A
and Caan BJ: High- and low-fat dairy intake, recurrence, and
mortality after breast cancer diagnosis. J Natl Cancer Inst.
105:616–623. 2013.PubMed/NCBI View Article : Google Scholar
|
|
33
|
He Y, Tao Q, Zhou F, Si Y, Fu R, Xu B, Xu
J, Li X and Chen B: The relationship between dairy products intake
and breast cancer incidence: A meta-analysis of observational
studies. BMC Cancer. 21(1109)2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Wajszczyk B, Charzewska J, Godlewski D,
Zemła B, Nowakowska E, Kozaczka M, Chilimoniuk M and Pathak DR:
Consumption of dairy products and the risk of developing breast
cancer in Polish women. Nutrients. 13(4420)2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Melnik BC, John SM, Carrera-Bastos P,
Cordain L, Leitzmann C, Weiskirchen R and Schmitz G: The role of
Cow's milk consumption in breast cancer initiation and progression.
Curr Nutr Rep. 12:122–140. 2023.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Sirajudeen S, Shah I and Al*Menhali A: A
narrative role of vitamin D and its receptor: With current evidence
on the gastric tissues. Int J Mol Sci. 20(3832)2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Benedik E: Sources of vitamin D for
humans. Int J Vitam Nutr Res. 92:118–125. 2022.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Falzone L: Role of vitamin D in health and
disease: How diet may improve vitamin D absorption. Int J Food Sci
Nutr. 74:121–123. 2023.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Marino R and Misra M: Extra-skeletal
effects of vitamin D. Nutrients. 11(1460)2019.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Zmijewski MA: Vitamin D and human health.
Int J Mol Sci. 20(145)2019.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Giustina A, Adler RA, Binkley N,
Bollerslev J, Bouillon R, Dawson-Hughes B, Ebeling PR, Feldman D,
Formenti AM, Lazaretti-Castro M, et al: Consensus statement from
2nd international conference on controversies in vitamin D. Rev
Endocr Metab Disord. 21:89–116. 2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Chauhan K, Shahrokhi M and Huecker MR:
Vitamin D. In: StatPearls [Internet]. StatPearls Publishing,
Treasure Island, FL, 2023. https://www.ncbi.nlm.nih.gov/books/NBK441912/.
Updated April 9, 2023.
|
|
43
|
Malik MZ, Latiwesh OB, Nouh F, Hussain A,
Kumar S and Kaler J: Response of parathyroid hormone to vitamin D
deficiency in otherwise healthy individuals. Cureus.
12(e9764)2020.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Goltzman D, Mannstadt M and Marcocci C:
Physiology of the calcium-parathyroid hormone-vitamin D axis. Front
Horm Res. 50:1–13. 2018.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Naeem Z: Vitamin D deficiency- an ignored
epidemic. Int J Health Sci (Qassim). 4:5–6. 2010.PubMed/NCBI
|
|
46
|
Marcinowska-Suchowierska E,
Kupisz-Urbańska M, Łukaszkiewicz J, Płudowski P and Jones G:
Vitamin D toxicity-A clinical perspective. Front Endocrinol
(Lausanne). 9(550)2018.PubMed/NCBI View Article : Google Scholar
|
|
47
|
McDonnell SL, Baggerly CA, French CB,
Baggerly LL, Garland CF, Gorham ED, Hollis BW, Trump DL and Lappe
JM: Breast cancer risk markedly lower with serum 25-hydroxyvitamin
D concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/l): Pooled
analysis of two randomized trials and a prospective cohort. PLoS
One. 13(e0199265)2018.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Vanhevel J, Verlinden L, Doms S, Wildiers
H and Verstuyf A: The role of vitamin D in breast cancer risk and
progression. Endocr Relat Cancer. 29:R33–R55. 2022.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Jeon SM and Shin EA: Exploring vitamin D
metabolism and function in cancer. Exp Mol Med. 50:1–14.
2018.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Puspitaningtyas H, Sulistyoningrum DC,
Witaningrum R, Widodo I, Hardianti MS, Taroeno-Hariadi KW,
Kurnianda J, Purwanto I and Hutajulu SH: Vitamin D status in breast
cancer cases following chemotherapy: A pre and post observational
study in a tertiary hospital in Yogyakarta, Indonesia. PLoS One.
17(e0270507)2022.PubMed/NCBI View Article : Google Scholar
|
|
51
|
de La Puente-Yagüe M, Cuadrado-Cenzual MA,
Ciudad-Cabañas MJ, Hernández-Cabria M and Collado-Yurrita L:
Vitamin D: And its role in breast cancer. Kaohsiung J Med Sci.
34:423–427. 2018.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Yao S, Kwan ML, Ergas IJ, Roh JM, Cheng
TD, Hong CC, McCann SE, Tang L, Davis W, Liu S, et al: Association
of serum level of vitamin D at diagnosis with breast cancer
survival: A case-cohort analysis in the pathways study. JAMA Oncol.
3:351–357. 2017.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Augustin LS, Libra M, Crispo A, Grimaldi
M, De Laurentiis M, Rinaldo M, D'Aiuto M, Catalano F, Banna G,
Ferrau' F, et al: Low glycemic index diet, exercise and vitamin D
to reduce breast cancer recurrence (DEDiCa): Design of a clinical
trial. BMC Cancer. 17(69)2017.PubMed/NCBI View Article : Google Scholar
|
|
54
|
O'Brien J, Hayder H, Zayed Y and Peng C:
Overview of MicroRNA biogenesis, mechanisms of actions, and
circulation. Front Endocrinol (Lausanne). 9(402)2018.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer.
94:776–780. 2006.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Azlan A, Rajasegaran Y, Kang Zi K, Rosli
AA, Yik MY, Yusoff NM, Heidenreich O and Moses EJ: Elucidating
miRNA function in cancer biology via the molecular genetics'
toolbox. Biomedicines. 10(915)2022.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Filetti V, La Ferlita A, Di Maria A,
Cardile V, Graziano ACE, Rapisarda V, Ledda C, Pulvirenti A and
Loreto C: Dysregulation of microRNAs and tRNA-derived ncRNAs in
mesothelial and mesothelioma cell lines after asbestiform fiber
exposure. Sci Rep. 12(9181)2022.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Filetti V, Lombardo C, Loreto C, Dounias
G, Bracci M, Matera S, Rapisarda L, Rapisarda V, Ledda C and Vitale
E: Small RNA-Seq transcriptome profiling of mesothelial and
mesothelioma cell lines revealed microrna dysregulation after
exposure to asbestos-like fibers. Biomedicines.
11(538)2023.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Calin GA, Sevignani C, Dumitru CD, Hyslop
T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M
and Croce CM: Human microRNA genes are frequently located at
fragile sites and genomic regions involved in cancers. Proc Natl
Acad Sci USA. 101:2999–3004. 2004.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Jang JH and Lee TJ: The role of microRNAs
in cell death pathways. Yeungnam Univ J Med. 38:107–117.
2021.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Hao S, Huo S, Du Z, Yang Q, Ren M, Liu S,
Liu T and Zhang G: MicroRNA-related transcription factor regulatory
networks in human colorectal cancer. Medicine (Baltimore).
98(e15158)2019.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Santolla MF, Lappano R, Cirillo F,
Rigiracciolo DC, Sebastiani A, Abonante S, Tassone P, Tagliaferri
P, Di Martino MT, Maggiolini M and Vivacqua A: miR-221 stimulates
breast cancer cells and cancer-associated fibroblasts (CAFs)
through selective interference with the A20/c-Rel/CTGF signaling. J
Exp Clin Cancer Res. 37(94)2018.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Lambertini E, Lolli A, Vezzali F,
Penolazzi L, Gambari R and Piva R: Correlation between Slug
transcription factor and miR-221 in MDA-MB-231 breast cancer cells.
BMC Cancer. 12(445)2012.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Di Leva G, Gasparini P, Piovan C, Ngankeu
A, Garofalo M, Taccioli C, Iorio MV, Li M, Volinia S, Alder H, et
al: MicroRNA cluster 221-222 and estrogen receptor alpha
interactions in breast cancer. J Natl Cancer Inst. 102:706–721.
2010.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Garofalo M, Quintavalle C, Romano G, Croce
CM and Condorelli G: miR221/222 in cancer: Their role in tumor
progression and response to therapy. Curr Mol Med. 12:27–33.
2012.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Ma L: Role of miR-10b in breast cancer
metastasis. Breast Cancer Res. 12(210)2010.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Korpal M, Lee ES, Hu G and Kang Y: The
miR-200 family inhibits epithelial-mesenchymal transition and
cancer cell migration by direct targeting of E-cadherin
transcriptional repressors ZEB1 and ZEB2. J Biol Chem.
283:14910–14914. 2008.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Fontana A, Barbano R, Dama E, Pasculli B,
Rendina M, Morritti MG, Melocchi V, Castelvetere M, Valori VM,
Ravaioli S, et al: Combined analysis of miR-200 family and its
significance for breast cancer. Sci Rep. 11(2980)2021.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Klicka K, Grzywa TM, Mielniczuk A, Klinke
A and Włodarski PK: The role of miR-200 family in the regulation of
hallmarks of cancer. Front Oncol. 12(965231)2022.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Hossain MM, Sultana A, Barua D, Islam MN,
Gupta A and Gupta S: Differential expression, function and
prognostic value of miR-17-92 cluster in ER-positive and
triple-negative breast cancer. Cancer Treat Res Commun.
25(100224)2020.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Ventura A, Young AG, Winslow MM, Lintault
L, Meissner A, Erkeland SJ, Newman J, Bronson RT, Crowley D, Stone
JR, et al: Targeted deletion reveals essential and overlapping
functions of the miR-17 through 92 family of miRNA clusters. Cell.
132:875–186. 2008.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Imani S, Wu RC and Fu J: MicroRNA-34
family in breast cancer: From research to therapeutic potential. J
Cancer. 9:3765–3775. 2018.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Tang W, Li GS, Li JD, Pan WY, Shi Q, Xiong
DD, Mo CH, Zeng JJ, Chen G, Feng ZB, et al: The role of upregulated
miR-375 expression in breast cancer: An in vitro and in silico
study. Pathol Res Pract. 216(152754)2020.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Liu X, Papukashvili D, Wang Z, Liu Y, Chen
X, Li J, Li Z, Hu L, Li Z, Rcheulishvili N, et al: Potential
utility of miRNAs for liquid biopsy in breast cancer. Front Oncol.
12(940314)2022.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Gattuso G, Crimi S, Lavoro A, Rizzo R,
Musumarra G, Gallo S, Facciponte F, Paratore S, Russo A, Bordonaro
R, et al: Liquid biopsy and circulating biomarkers for the
diagnosis of precancerous and cancerous oral lesions. Noncoding
RNA. 8(60)2022.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Liu Y, Tang D, Zheng S, Su R and Tang Y:
Serum microRNA-195 as a potential diagnostic biomarker for breast
cancer: A systematic review and meta-analysis. Int J Clin Exp
Pathol. 12:3982–3991. 2019.PubMed/NCBI
|
|
78
|
Eichelser C, Flesch-Janys D, Chang-Claude
J, Pantel K and Schwarzenbach H: Deregulated serum concentrations
of circulating cell-free microRNAs miR-17, miR-34a, miR-155, and
miR-373 in human breast cancer development and progression. Clin
Chem. 59:1489–1496. 2013.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Fortis SP, Vaxevanis CK, Mahaira LG,
Sofopoulos M, Sotiriadou NN, Dinou A, Arnogiannaki N,
Stavropoulos-Giokas C, Thanos D, Baxevanis CN and Perez SA: Serum
miRNA-based distinct clusters define three groups of breast cancer
patients with different clinicopathological and immune
characteristics. Cancer Immunol Immunother. 68:57–70.
2019.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Cardinali B, Tasso R, Piccioli P, Ciferri
MC, Quarto R and Del*Mastro L: Circulating miRNAs in breast cancer
diagnosis and prognosis. Cancers (Basel). 14(2317)2022.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Gambari R, Brognara E, Spandidos DA and
Fabbri E: Targeting oncomiRNAs and mimicking tumor suppressor
miRNAs: Νew trends in the development of miRNA therapeutic
strategies in oncology (Review). Int J Oncol. 49:5–32.
2016.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Falzone L, Grimaldi M, Celentano E,
Augustin LSA and Libra M: Identification of modulated MicroRNAs
associated with breast cancer, diet, and physical activity. Cancers
(Basel). 12(2555)2020.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Olson J, Sheean P, Matthews L, Chitambar
CR, Banerjee A, Visotcky A, Bonini M and Stolley M: Circulating
miRNAs as early indicators of diet and physical activity response
in women with metastatic breast cancer. Future Sci OA.
7(FSO694)2021.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Humphries B, Wang Z and Yang C: MicroRNA
regulation of epigenetic modifiers in breast cancer. Cancers
(Basel). 11(897)2019.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Momi N, Kaur S, Rachagani S, Ganti AK and
Batra SK: Smoking and microRNA dysregulation: A cancerous
combination. Trends Mol Med. 20:36–47. 2014.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Giambò F, Leone GM, Gattuso G, Rizzo R,
Cosentino A, Cinà D, Teodoro M, Costa C, Tsatsakis A, Fenga C and
Falzone L: Genetic and epigenetic alterations induced by pesticide
exposure: Integrated analysis of gene expression, microRNA
expression, and DNA methylation datasets. Int J Environ Res Public
Health. 18(8697)2021.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Gattuso G, Falzone L, Costa C, Giambò F,
Teodoro M, Vivarelli S, Libra M and Fenga C: Chronic pesticide
exposure in farm workers is associated with the epigenetic
modulation of hsa-miR-199a-5p. Int J Environ Res Public Health.
19(7018)2022.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Krauskopf J, de Kok TM, Hebels DG,
Bergdahl IA, Johansson A, Spaeth F, Kiviranta H, Rantakokko P,
Kyrtopoulos SA and Kleinjans JC: MicroRNA profile for health risk
assessment: Environmental exposure to persistent organic pollutants
strongly affects the human blood microRNA machinery. Sci Rep.
7(9262)2017.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Bailey KA and Fry RC: Arsenic-associated
changes to the epigenome: What are the functional consequences?
Curr Environ Health Rep. 1:22–34. 2014.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Kasiappan R and Rajarajan D: Role of
MicroRNA regulation in obesity-associated breast cancer:
Nutritional perspectives. Adv Nutr. 8:868–888. 2017.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Kwon YJ, Cho YE, Cho AR, Choi WJ, Yun S,
Park H, Kim HS, Cashion AK, Gill J, Lee H and Lee JW: The possible
influence of mediterranean diet on extracellular vesicle miRNA
expression in breast cancer survivors. Cancers (Basel).
12(1355)2020.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Blasiak J, Chojnacki J, Pawlowska E,
Jablkowska A and Chojnacki C: Vitamin D may protect against breast
cancer through the regulation of long noncoding RNAs by VDR
signaling. Int J Mol Sci. 23(3189)2022.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Socha M and Sobiech KA: Eating habits,
risk of breast cancer, and diet-dependent quality of life in
postmenopausal women after mastectomy. J Clin Med.
11(4287)2022.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Adinew GM, Taka E, Mendonca P, Messeha SS
and Soliman KFA: The anticancer effects of flavonoids through
miRNAs modulations in triple-negative breast cancer. Nutrients.
13(1212)2021.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Zabaleta ME, Forbes-Hernández TY,
Simal-Gandara J, Quiles JL, Cianciosi D, Bullon B, Giampieri F and
Battino M: Effect of polyphenols on HER2-positive breast cancer and
related miRNAs: Epigenomic regulation. Food Res Int.
137(109623)2020.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Otsuka K, Yamamoto Y and Ochiya T:
Regulatory role of resveratrol, a microRNA-controlling compound, in
HNRNPA1 expression, which is associated with poor prognosis in
breast cancer. Oncotarget. 9:24718–24730. 2018.PubMed/NCBI View Article : Google Scholar
|
|
97
|
LeMay-Nedjelski L, Mason-Ennis JK, Taibi
A, Comelli EM and Thompson LU: Omega-3 polyunsaturated fatty acids
time-dependently reduce cell viability and oncogenic MicroRNA-21
expression in estrogen receptor-positive breast cancer cells
(MCF-7). Int J Mol Sci. 19(244)2018.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Cui J, Zhou B, Ross SA and Zempleni J:
Nutrition, microRNAs, and Human Health. Adv Nutr. 8:105–112.
2017.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Quintanilha BJ, Reis BZ, Duarte GBS,
Cozzolino SMF and Rogero MM: Nutrimiromics: Role of microRNAs and
nutrition in modulating inflammation and chronic diseases.
Nutrients. 9(1168)2017.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Milenkovic D, Jude B and Morand C: miRNA
as molecular target of polyphenols underlying their biological
effects. Free Radic Biol Med. 64:40–51. 2013.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Zhang Y, Yu B, He J and Chen D: From
nutrient to MicroRNA: a novel insight into cell signaling involved
in skeletal muscle development and disease. Int J Biol Sci.
12:1247–1261. 2016.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Shaikh AA, Braakhuis AJ and Bishop KS: The
mediterranean diet and breast cancer: A personalised approach.
Healthcare (Basel). 7(104)2019.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Garland CF, Garland FC, Gorham ED, Lipkin
M, Newmark H, Mohr SB and Holick MF: The role of vitamin D in
cancer prevention. Am J Public Health. 96:252–261. 2006.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Gandini S, Boniol M, Haukka J, Byrnes G,
Cox B, Sneyd MJ, Mullie P and Autier P: Meta-analysis of
observational studies of serum 25-hydroxyvitamin D levels and
colorectal, breast and prostate cancer and colorectal adenoma. Int
J Cancer. 128:1414–1424. 2011.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Hu K, Callen DF, Li J and Zheng H:
Circulating vitamin D and overall survival in breast cancer
patients: A dose-response meta-analysis of cohort studies. Integr
Cancer Ther. 17:217–225. 2018.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Ling Y, Xu F, Xia X, Dai D, Sun R and Xie
Z: Vitamin D receptor regulates proliferation and differentiation
of thyroid carcinoma via the E-cadherin-β-catenin complex. J Mol
Endocrinol. 68:137–151. 2022.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Ferrero G, Carpi S, Polini B, Pardini B,
Nieri P, Impeduglia A, Grioni S, Tarallo S and Naccarati A: Intake
of natural compounds and circulating microRNA expression levels:
Their relationship investigated in healthy subjects with different
dietary habits. Front Pharmacol. 11(619200)2021.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Kura B, Parikh M, Slezak J and Pierce GN:
The influence of diet on MicroRNAs that impact cardiovascular
disease. Molecules. 24(1509)2019.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Uberti F, Morsanuto V, Aprile S, Ghirlanda
S, Stoppa I, Cochis A, Grosa G, Rimondini L and Molinari C:
Biological effects of combined resveratrol and vitamin D3 on
ovarian tissue. J Ovarian Res. 10(61)2017.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Biersack B: Current state of phenolic and
terpenoidal dietary factors and natural products as non-coding
RNA/microRNA modulators for improved cancer therapy and prevention.
Noncoding RNA Res. 1:12–34. 2016.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Kocic H, Damiani G, Stamenkovic B, Tirant
M, Jovic A, Tiodorovic D and Peris K: Dietary compounds as
potential modulators of microRNA expression in psoriasis. Ther Adv
Chronic Dis. 10(2040622319864805)2019.PubMed/NCBI View Article : Google Scholar
|
|
112
|
Gleba JJ, Kłopotowska D, Banach J, Mielko
KA, Turlej E, Maciejewska M, Kutner A and Wietrzyk J: Micro-RNAs in
response to active forms of vitamin D3 in human leukemia and
lymphoma cells. Int J Mol Sci. 23(5019)2022.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Mohri T, Nakajima M, Takagi S, Komagata S
and Yokoi T: MicroRNA regulates human vitamin D receptor. Int J
Cancer. 125:1328–1333. 2009.PubMed/NCBI View Article : Google Scholar
|
|
114
|
Wahler J, So JY, Kim YC, Liu F, Maehr H,
Uskokovic M and Suh N: Inhibition of the transition of ductal
carcinoma in situ to invasive ductal carcinoma by a Gemini vitamin
D analog. Cancer Prev Res (Phila). 7:617–626. 2014.PubMed/NCBI View Article : Google Scholar
|
|
115
|
Wahler J, Cheng LC, Maehr H, Uskokovic M
and Suh N: Abstract 1912: Reduction of microRNA-21 by vitamin D
compounds during ductal carcinoma in situ transition to invasive
ductal carcinoma. Cancer Res. 75 (15 Suppl)(S1912)2015.
|
|
116
|
Singh T and Adams BD: The regulatory role
of miRNAs on VDR in breast cancer. Transcription. 8:232–241.
2017.PubMed/NCBI View Article : Google Scholar
|
|
117
|
Essa S, Reichrath S, Mahlknecht U,
Montenarh M, Vogt T and Reichrath J: Signature of VDR miRNAs and
epigenetic modulation of vitamin D signaling in melanoma cell
lines. Anticancer Res. 32:383–389. 2012.PubMed/NCBI
|
|
118
|
Liu X, Bi L, Wang Q, Wen M, Li C, Ren Y,
Jiao Q, Mao JH, Wang C, Wei G and Wang Y: miR-1204 targets VDR to
promotes epithelial-mesenchymal transition and metastasis in breast
cancer. Oncogene. 37:3426–3439. 2018.PubMed/NCBI View Article : Google Scholar
|
|
119
|
Goodwin PJ, Ennis M, Pritchard KI, Koo J
and Hood N: Prognostic effects of 25-hydroxyvitamin D levels in
early breast cancer. J Clin Oncol. 27:3757–3763. 2009.PubMed/NCBI View Article : Google Scholar
|
|
120
|
Peng X, Vaishnav A, Murillo G, Alimirah F,
Torres KEO and Mehta RG: Protection against cellular stress by
25-hydroxyvitamin D3 in breast epithelial cells. J Cell Biochem.
110:1324–1333. 2010.PubMed/NCBI View Article : Google Scholar
|
|
121
|
Huang FY, Wong DKH, Seto WK, Lai CL and
Yuen MF: Estradiol induces apoptosis via activation of miRNA-23a
and p53: Implication for gender difference in liver cancer
development. Oncotarget. 6:34941–34952. 2015.PubMed/NCBI View Article : Google Scholar
|
|
122
|
Zhang F, Wang B, Long H, Yu J, Li F, Hou H
and Yang Q: Decreased miR-124-3p expression prompted breast cancer
cell progression mainly by targeting beclin-1. Clin Lab.
62:1139–1145. 2016.PubMed/NCBI View Article : Google Scholar
|
|
123
|
Li Y, Cook KL, Yu W, Jin L, Bouker KB,
Clarke R and Hilakivi-Clarke L: Inhibition of antiestrogen-promoted
pro-survival autophagy and tamoxifen resistance in breast cancer
through vitamin D receptor. Nutrients. 13(1715)2021.PubMed/NCBI View Article : Google Scholar
|
|
124
|
Wang Y, Wei Y, Fan X, Zhang P, Wang P,
Cheng S and Zhang J: MicroRNA-125b as a tumor suppressor by
targeting MMP11 in breast cancer. Thorac Cancer. 11:1613–1620.
2020.PubMed/NCBI View Article : Google Scholar
|
|
125
|
Scott GK, Goga A, Bhaumik D, Berger CE,
Sullivan CS and Benz CC: Coordinate suppression of ERBB2 and ERBB3
by enforced expression of micro-RNA miR-125a or miR-125b. J Biol
Chem. 282:1479–1486. 2007.PubMed/NCBI View Article : Google Scholar
|
|
126
|
Shahrzad MK, Gharehgozlou R, Fadaei S,
Hajian P and Mirzaei HR: Vitamin D and non-coding RNAs: New
insights into the regulation of breast cancer. Curr Mol Med.
21:194–210. 2021.PubMed/NCBI View Article : Google Scholar
|
